Daniel B. Mark
About
Daniel B. Mark is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery.
According to data from OpenAlex, Daniel B. Mark has authored 497 papers receiving a total of 52.7k indexed citations (citations by other indexed papers that have themselves been cited), including 355 papers in Cardiology and Cardiovascular Medicine, 125 papers in Radiology, Nuclear Medicine and Imaging and 120 papers in Surgery. Recurrent topics in Daniel B. Mark's work include Cardiac Imaging and Diagnostics (124 papers), Acute Myocardial Infarction Research (104 papers) and Cardiac pacing and defibrillation studies (92 papers). Daniel B. Mark is often cited by papers focused on Cardiac Imaging and Diagnostics (124 papers), Acute Myocardial Infarction Research (104 papers) and Cardiac pacing and defibrillation studies (92 papers). Daniel B. Mark collaborates with scholars based in United States, Canada and United Kingdom. Daniel B. Mark's co-authors include Kerry L. Lee, Frank E. Harrell, Mark A. Hlatky, David B. Pryor, Robert M. Califf, Jeanne E. Poole, Gust H. Bardy, Nancy E. Clapp‐Channing, Jill Anderson and Eric D. Peterson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.
In The Last Decade
Daniel B. Mark
484 papers receiving 50.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Daniel B. Mark United States | 102 | 33.3k | 13.2k | 12.0k | 4.9k | 3.9k | 497 | 52.7k | ||
| Roger S. Blumenthal United States | 98 | 20.5k 0.6× | 12.2k 0.9× | 10.7k 0.9× | 3.6k 0.7× | 2.7k 0.7× | 762 | 44.8k | ||
| Philip Greenland United States | 95 | 20.2k 0.6× | 13.3k 1.0× | 8.7k 0.7× | 5.2k 1.1× | 2.8k 0.7× | 457 | 45.1k | ||
| Mark A. Hlatky United States | 85 | 23.8k 0.7× | 8.3k 0.6× | 6.6k 0.5× | 2.8k 0.6× | 3.0k 0.8× | 406 | 36.4k | ||
| Gregory L. Burke United States | 102 | 21.6k 0.6× | 8.2k 0.6× | 8.0k 0.7× | 7.6k 1.5× | 5.2k 1.3× | 347 | 57.6k | ||
| Bernard J. Gersh United States | 138 | 61.8k 1.9× | 19.2k 1.5× | 13.7k 1.1× | 6.8k 1.4× | 2.7k 0.7× | 1.1k | 76.6k | ||
| Martin G. Larson United States | 142 | 53.4k 1.6× | 12.7k 1.0× | 6.6k 0.6× | 8.0k 1.6× | 2.2k 0.6× | 587 | 89.4k | ||
| Sidney C. Smith United States | 90 | 27.3k 0.8× | 19.6k 1.5× | 6.7k 0.6× | 4.5k 0.9× | 5.9k 1.5× | 317 | 67.7k | ||
| John G.F. Cleland United Kingdom | 126 | 52.9k 1.6× | 8.2k 0.6× | 4.1k 0.3× | 8.2k 1.7× | 2.4k 0.6× | 1.3k | 75.9k | ||
| Véronique L. Roger United States | 102 | 25.0k 0.8× | 5.5k 0.4× | 5.0k 0.4× | 3.8k 0.8× | 2.0k 0.5× | 448 | 38.1k | ||
| Donald M. Lloyd‐Jones United States | 105 | 34.7k 1.0× | 18.0k 1.4× | 6.4k 0.5× | 4.5k 0.9× | 7.1k 1.8× | 739 | 69.0k |
Countries citing papers authored by Daniel B. Mark
Since
Specialization
Citations
This map shows the geographic impact of Daniel B. Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel B. Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel B. Mark more than expected).
Fields of papers citing papers by Daniel B. Mark
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Daniel B. Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel B. Mark. The network helps show where Daniel B. Mark may publish in the future.
Co-authorship network of co-authors of Daniel B. Mark
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel B. Mark. A scholar is included among the top collaborators of Daniel B. Mark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel B. Mark. Daniel B. Mark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kaltenbach, Lisa A., Daniel B. Mark, Audrey L. Blewer, et al.. (2025). Public awareness of automated external defibrillator (AED)s and their location: Results of a cross-sectional survey in North Carolina. Resuscitation Plus. 22. 100897–100897.
2.
Mark, Daniel B., Michael G. Nanna, Michelle D. Kelsey, et al.. (2025). Quality of Life Outcomes With a Risk-Based Precision Testing Strategy Versus Usual Testing in Stable Patients With Suspected Coronary Disease: Results From the PRECISE Randomized Trial. Circulation Cardiovascular Quality and Outcomes. 18(2). e011414–e011414.
3.
Pun, Patrick H., Konstantin A. Krychtiuk, Christopher B. Granger, et al.. (2024). Public access defibrillator locations and details in Forsyth County, North Carolina: Results of a telephone survey canvas of large businesses to facilitate out-of-hospital cardiac arrest treatment. The American Journal of Emergency Medicine. 85. 166–171.
4.
Monahan, Kristi H., T. Jared Bunch, Daniel B. Mark, et al.. (2022). Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA. EP Europace. 24(9). 1430–1440.
5.
Packer, Douglas L., Jonathan P. Piccini, Kristi H. Monahan, et al.. (2021). Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure. Circulation. 143(14). 1377–1390.
6.
Rettmann, Maryam E., David R. Holmes, Kristi H. Monahan, et al.. (2021). Treatment-Related Changes in Left Atrial Structure in Atrial Fibrillation: Findings From the CABANA Imaging Substudy. Circulation Arrhythmia and Electrophysiology. 14(5). e008540–e008540.
7.
Bahnson, Tristram D., Anna Giczewska, Daniel B. Mark, et al.. (2021). Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial. Circulation. 145(11). 796–804.
8.
Chew, Derek S., Eric Black‐Maier, Zak Loring, et al.. (2020). Diagnosis-to-Ablation Time and Recurrence of Atrial Fibrillation Following Catheter Ablation. Circulation Arrhythmia and Electrophysiology. 13(4). e008128–e008128.
9.
Poole, Jeanne E., Brian Olshansky, Daniel B. Mark, et al.. (2020). Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT. Journal of the American College of Cardiology. 76(4). 405–415.
10.
Chew, Derek S., Zak Loring, Marat Fudim, et al.. (2020). Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction. Circulation Cardiovascular Quality and Outcomes. 13(12). e007094–e007094.
11.
Kaul, Padma, E. Magnus Ohman, J. David Knight, et al.. (2016). Health-related quality of life outcomes with prasugrel among medically managed non–ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial. American Heart Journal. 178. 55–64.
12.
Alexander, Karen P., Giora Weisz, Kristi Prather, et al.. (2015). Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization. Circulation. 133(1). 39–47.
13.
Lamas, Gervasio A., Christine Goertz, Robin Boineau, et al.. (2014). Disodium EDTA Chelation for Post Myocardial Infarction Patients. The Journal of Alternative and Complementary Medicine. 20(5). A2–A2.
14.
Lamas, Gervasio A., Robin Boineau, Christine Goertz, et al.. (2014). Oral High-Dose Multivitamins and Minerals Alone and in Combination with Chelation Therapy for Coronary Disease: A Randomized Clinical Trial. The Journal of Alternative and Complementary Medicine. 20(5). A2–A3.
15.
Packer, Douglas L., Jordan M. Prutkin, Anne S. Hellkamp, et al.. (2009). Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure. Circulation. 120(22). 2170–2176.
16.
Poole, Jeanne E., George Johnson, Anne S. Hellkamp, et al.. (2006). AB19-5. Heart Rhythm. 3(5). S40–S40.
17.
Brummett, Beverly H., Daniel B. Mark, Ilene C. Siegler, et al.. (2005). Perceived Social Support as a Predictor of Mortality in Coronary Patients: Effects of Smoking, Sedentary Behavior, and Depressive Symptoms. Psychosomatic Medicine. 67(1). 40–45.
18.
Reed, Shelby D., Kevin J. Anstrom, Ameet Bakhai, et al.. (2005). Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus. American Heart Journal. 149(3). 434–443.
19.
Mark, Daniel B.. (2003). [Scientific session of the Institute of Tuberculosis of the Academy of Medicine of USSR].. PubMed. 5. 75–8.
20.
Bengtson, James R., Daniel B. Mark, Michael B. Honan, et al.. (1990). Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test. The American Journal of Cardiology. 65(1). 28–34.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Roger S. Blumenthal Breakdown of academic impact, for papers by Philip Greenland Breakdown of academic impact, for papers by Mark A. Hlatky Breakdown of academic impact, for papers by Gregory L. Burke Breakdown of academic impact, for papers by Bernard J. Gersh Breakdown of academic impact, for papers by Martin G. Larson Breakdown of academic impact, for papers by Sidney C. Smith Breakdown of academic impact, for papers by John G.F. Cleland Breakdown of academic impact, for papers by Véronique L. Roger Breakdown of academic impact, for papers by Donald M. Lloyd‐Jones